CLCN6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.02499999999439E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.76069999691109E-08 |
Normal-vs-Stage2 |
4.317700E-02 |
Normal-vs-Stage3 |
1.418990E-01 |
Normal-vs-Stage4 |
7.843200E-01 |
Stage1-vs-Stage2 |
1.890430E-01 |
Stage1-vs-Stage3 |
2.039500E-03 |
Stage1-vs-Stage4 |
2.02559999999963E-05 |
Stage2-vs-Stage3 |
3.534000E-01 |
Stage2-vs-Stage4 |
9.061800E-02 |
Stage3-vs-Stage4 |
3.202000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.987070E-04 |
Normal-vs-AfricanAmerican |
2.355800E-04 |
Normal-vs-Asian |
5.673600E-02 |
Caucasian-vs-AfricanAmerican |
1.008400E-01 |
Caucasian-vs-Asian |
1.154170E-01 |
AfricanAmerican-vs-Asian |
3.415600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.900800E-03 |
Normal-vs-Female |
6.95780000281587E-08 |
Male-vs-Female |
3.001900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.411400E-01 |
Normal-vs-Age(41-60Yrs) |
1.41030000000431E-06 |
Normal-vs-Age(61-80Yrs) |
5.462900E-03 |
Normal-vs-Age(81-100Yrs) |
2.347000E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.253000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.196600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.035400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.493800E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.681000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.737400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.90359999996392E-06 |
Normal-vs-Grade 2 |
7.90410004114506E-09 |
Normal-vs-Grade 3 |
3.080100E-02 |
Normal-vs-Grade 4 |
1.156400E-01 |
Grade 1-vs-Grade 2 |
5.408800E-04 |
Grade 1-vs-Grade 3 |
8.21559997810084E-09 |
Grade 1-vs-Grade 4 |
1.77635683940025E-13 |
Grade 2-vs-Grade 3 |
1.238840E-04 |
Grade 2-vs-Grade 4 |
1.3067003035161E-10 |
Grade 3-vs-Grade 4 |
6.620800E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
8.78186412478499E-14 |
Normal-vs-ccB subtype |
6.710200E-01 |
ccA subtype-vs-ccB subtype |
6.45039577307216E-14 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.157300E-04 |
Normal-vs-N1 |
5.874000E-02 |
N0-vs-N1 |
3.175500E-04 |
|
|